Skip to main content
SpringerLink
Log in

Fortgeschrittene Leberzirrhose: Betablocker offenbar schädlich

  • AKTUELLE MEDIZIN_KRITISCH GELESEN
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Bei Patienten mit fortgeschrittener Leberzirrhose und spontan bakterieller Peritonitis erhöhten nicht-selektive β-Blocker die Risiken für ein hepatorenales Syndrom, akutes Nierenversagen und vorzeitige Mortalität.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Mandorfer M et al. Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis. Gastroenterology 2014;146:1680–1690

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    H. H. Lutz &  J. J. W. Tischendorf

Authors
  1. H. H. Lutz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. J. W. Tischendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lutz, H.H., Tischendorf, J.J.W. Fortgeschrittene Leberzirrhose: Betablocker offenbar schädlich. MMW - Fortschritte der Medizin 156 (Suppl 6), 35 (2014). https://doi.org/10.1007/s15006-014-3689-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-014-3689-z

Search

Navigation